Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Westman

Showing results (11-20 of 296) with videos related to

Pageof 30
Sort By:
Neurobiology of Aging|July 11, 2017
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's diseaseJoana B Pereira, Eric Westman, Oskar Hansson, et al.
Frontiers in Neuroinformatics|January 17, 2014
TheHiveDB image data management and analysis frameworkJ-Sebastian Muehlboeck, Eric Westman, Andrew Simmons
Alzheimer'S Research & Therapy|February 23, 2023
Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneityRosaleena Mohanty, Daniel Ferreira, Agneta Nordberg, et al.
The Lancet. Neurology|July 21, 2012
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatmentPer Svenningsson, Eric Westman, Clive Ballard, et al.
Research Square|February 20, 2025
Lower Network Functional Connectivity Is Associated With Higher Regional Tau Burden Among Those At-Risk of Alzheimer's Disease But Cognitively Unimpaired: Specific Patterns Based on Amyloid StatusJamie Ford, Rosaleena Mohanty, Eric Westman, et al.
Parkinsonism & Related Disorders|September 10, 2017
Quantitative susceptibility mapping differentiates between parkinsonian disordersHenrik Sjöström, Tobias Granberg, Eric Westman, et al.
Alzheimer'S Research & Therapy|April 13, 2023
Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneityRosaleena Mohanty, Daniel Ferreira, Agneta Nordberg, et al.
Neurobiology of Disease|February 13, 2007
Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph)Eric Westman, Christian Spenger, Lars-Olof Wahlund, et al.
Frontiers in Neurology|June 14, 2019
Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain AtrophyDaniel Ferreira, Joana B Pereira, Giovanni Volpe, et al.
Brain Topography|August 15, 2012
Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairmentEric Westman, Carlos Aguilar, J-Sebastian Muehlboeck, et al.
Pageof 30

Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
Neurobiology of Aging|July 11, 2017
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's diseaseJoana B Pereira, Eric Westman, Oskar Hansson, et al.
Frontiers in Neuroinformatics|January 17, 2014
TheHiveDB image data management and analysis frameworkJ-Sebastian Muehlboeck, Eric Westman, Andrew Simmons
Alzheimer'S Research & Therapy|February 23, 2023
Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneityRosaleena Mohanty, Daniel Ferreira, Agneta Nordberg, et al.
The Lancet. Neurology|July 21, 2012
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatmentPer Svenningsson, Eric Westman, Clive Ballard, et al.
Research Square|February 20, 2025
Lower Network Functional Connectivity Is Associated With Higher Regional Tau Burden Among Those At-Risk of Alzheimer's Disease But Cognitively Unimpaired: Specific Patterns Based on Amyloid StatusJamie Ford, Rosaleena Mohanty, Eric Westman, et al.
Parkinsonism & Related Disorders|September 10, 2017
Quantitative susceptibility mapping differentiates between parkinsonian disordersHenrik Sjöström, Tobias Granberg, Eric Westman, et al.
Alzheimer'S Research & Therapy|April 13, 2023
Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneityRosaleena Mohanty, Daniel Ferreira, Agneta Nordberg, et al.
Neurobiology of Disease|February 13, 2007
Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph)Eric Westman, Christian Spenger, Lars-Olof Wahlund, et al.
Frontiers in Neurology|June 14, 2019
Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain AtrophyDaniel Ferreira, Joana B Pereira, Giovanni Volpe, et al.
Brain Topography|August 15, 2012
Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairmentEric Westman, Carlos Aguilar, J-Sebastian Muehlboeck, et al.
Pageof 30